Sinco Pharmaceuticals Holdings Management
Management criteria checks 3/4
Sinco Pharmaceuticals Holdings' CEO is Min Jin, appointed in Mar 2023, has a tenure of 1.67 years. total yearly compensation is CN¥1.96M, comprised of 94.6% salary and 5.4% bonuses, including company stock and options. directly owns 0.67% of the company’s shares, worth HK$2.57M. The average tenure of the management team and the board of directors is 1.8 years and 6 years respectively.
Key information
Min Jin
Chief executive officer
CN¥2.0m
Total compensation
| CEO salary percentage | 94.6% |
| CEO tenure | 1.7yrs |
| CEO ownership | 0.7% |
| Management average tenure | 1.8yrs |
| Board average tenure | 6yrs |
Recent management updates
Recent updates
What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You
Oct 04
Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Aug 16Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings
Apr 02Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks
Mar 08Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?
Nov 07A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Jun 26Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?
May 30Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet
Oct 26Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today
Feb 04I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease
Oct 25Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings
Jun 10Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt
May 24Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock
Apr 20We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings
Feb 16How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 11
Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?
Dec 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥47m |
| Mar 31 2024 | n/a | n/a | CN¥44m |
| Dec 31 2023 | CN¥2m | CN¥2m | CN¥42m |
| Sep 30 2023 | n/a | n/a | CN¥35m |
| Jun 30 2023 | n/a | n/a | CN¥27m |
| Mar 31 2023 | n/a | n/a | CN¥48m |
| Dec 31 2022 | CN¥2m | CN¥2m | CN¥69m |
Compensation vs Market: Min's total compensation ($USD272.91K) is about average for companies of similar size in the Hong Kong market ($USD236.00K).
Compensation vs Earnings: Min's compensation has been consistent with company performance over the past year.
CEO
Min Jin (46 yo)
1.7yrs
Tenure
CN¥1,959,000
Compensation
Mr. Min Jin is Chief Accountant since August 17, 2023 and Secretary since December 21, 2023 at Nanjing Tanker Corporation. He was Co-Chief Executive Officer at Sinco Pharmaceuticals Holdings Limited since...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 13.6yrs | CN¥7.10m | 51.65% HK$ 197.4m | |
| Chief Executive Officer | 1.7yrs | CN¥1.96m | 0.67% HK$ 2.6m | |
| Executive Director | no data | CN¥1.09m | no data | |
| Chief Financial Officer | 9.4yrs | no data | no data | |
| Executive Director | less than a year | no data | no data | |
| Company Secretary | 5.1yrs | no data | no data | |
| President of Sichuan Sinco Pharmaceuticals Co. Ltd. | 2yrs | no data | no data |
1.8yrs
Average Tenure
44yo
Average Age
Experienced Management: 6833's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 13.6yrs | CN¥7.10m | 51.65% HK$ 197.4m | |
| Executive Director | 1.7yrs | CN¥1.09m | no data | |
| Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 6yrs | CN¥300.00k | no data | |
| Independent Non-Executive Director | 8.8yrs | CN¥300.00k | no data | |
| Independent Non-Executive Director | 8.8yrs | CN¥300.00k | no data | |
| Independent Non-Executive Director | 4.2yrs | CN¥300.00k | no data |
6.0yrs
Average Tenure
58yo
Average Age
Experienced Board: 6833's board of directors are considered experienced (6 years average tenure).